Optios is a startup company founded in 2018 with a vision of leveraging neuroscience and technology to significantly enhance human performance. The company's mission is to explore the potential of neuroscience in transforming the human experience and creating new capabilities. Their approach is rooted in rigorous scientific research, making them a reliable entity in the emerging neuroperformance industry. Optios is engaged in Analytics and Biotechnology industries, aiming to capitalize on the immense value that the neuroperformance industry is expected to generate - estimated to be in the trillions of dollars. Their operations involve conducting in-depth, first-person research, employing top experts, and developing their proprietary deep technology tools to offer personalized recommendations to clients aligned with their business objectives and investment returns. As of now, there is no information available regarding the company's headquarters or its most recent investment and investors. Nevertheless, Optios presents a promising opportunity for venture capital firms seeking to explore the potential of applied neuroscience and technology in enhancing human performance.
There is no investment information
No recent news or press coverage available for Optios.